CVD Equipment Reports Weak Q4/FY2025 Results; Reaffirms SDC Division Sale for $16.9M
CVV sits 67% above its 52-week low of $2.46.
Summary
CVD Equipment reported a significant Q4 revenue decline and net loss, alongside a reduced backlog, while also reaffirming the strategic divestiture of its SDC division for $16.9 million to enhance financial flexibility.
Key Events · Earnings and Guidance · CVV
-
Q4 2025 Revenue Decline
Revenue fell 33.1% year-over-year to $5.0 million in Q4 2025, primarily reflecting lower CVD system sales.
-
Net Loss Reported
The company posted a net loss of ($1.3 million), or ($0.18) per basic and diluted share, in Q4 2025, compared with net income in the prior year quarter.
-
Backlog Reduction
Backlog decreased to $6.6 million at December 31, 2025, down from $8.0 million at September 30, 2025.
-
SDC Division Divestiture Confirmed
The filing reiterates the definitive agreement, announced on March 24, 2026, to sell the SDC business division for approximately $16.9 million, with net cash proceeds of about $15.0 million expected to enhance financial flexibility.
Analysis · CVV · Technology
This 8-K reports CVD Equipment's Q4 and fiscal year 2025 financial results, which show significant operational challenges including a 33.1% year-over-year revenue decline in Q4, a net loss, and a reduced backlog. These results highlight ongoing pressures from softer demand and geopolitical uncertainty. Concurrently, the filing reiterates the previously announced definitive agreement to sell the SDC business division for $16.9 million. While the operational performance is concerning, the divestiture, expected to yield approximately $15.0 million in net cash proceeds, is a critical strategic move to strengthen the balance sheet and provide financial flexibility. Investors will weigh the immediate operational weakness against the long-term strategic benefits and improved liquidity from the sale.
At the time of this filing, CVV was trading at $4.11 on NASDAQ in the Technology sector, with a market capitalization of approximately $31.6M. The 52-week trading range was $2.46 to $6.25. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.